Company News
4basebio losses widen as it progresses commercial development
4basebio, a biotechnology company specialising in synthetic DNA products and nucleic acid delivery platforms, reported revenue of over £0. 3m for the six months ended 30 June on Friday.
Moncler surges on LVMH deal
Moncler surged on Friday after LVMH bought a 10% stake in Double R, the investment vehicle controlled by the holding company owned by Moncler chief executive and chairman Remo Ruffini.
Helios Underwriting sees H1 profits rise
Insurance group and Lloyd's of London investment fund Helios Underwriting reported a small increase in operating profits in the first half despite a lower underwriting result.
International PPL partially sells FHSP investment
International Public Partnerships announced the partial disposal of its investment in the Family Housing Support Project (FHSP) on Friday, generating £30m.
Prudential expands in Indonesia through Syariah life insurance deal
Insurance and investment group Prudential said on Friday it has expanded further into South East Asia through a strategic partnership with Bank Syariah Indonesia.
PureTech receives $29m royalty from Karuna schizophrenia treatment
Clinical-stage biotherapeutics company PureTech Health has announced that the schizophrenia treatment it developed, which was later sold to Bristol Myers Squibb, has been approved by US regulators, triggering milestone payment and unlocking potential future royalties.